Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advances in Radiological Imaging for Thoracic Oncology: A 20-Year Perspective.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same author

Lung Injury after Precision Radiotherapy: Temporal Evolution, Potential Pitfalls, and Complications.

Radiographics : a review publication of the Radiological Society of North America, Inc·2026
Same author

Global Challenges in the Provision of Theranostic Services the International Atomic Energy Agency (IAEA) Perspective.

World journal of nuclear medicine·2025
Same author

Atypical Pulmonary Metastases: Patterns and Clinical Significance.

Radiographics : a review publication of the Radiological Society of North America, Inc·2025
Same author

Is <sup>18</sup>F-FDG-PET/CT useful in staging of locally advanced signet-ring cell esophageal adenocarcinoma?

Clinical imaging·2025
Same author

Assessing the Effectiveness of Selective RET Inhibitors in RET-Positive Cancers through Fluorodeoxyglucose Uptake Analysis.

Diagnostics (Basel, Switzerland)·2024

Related Experiment Video

Updated: May 21, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

Low-sensitivity FDG-PET studies: less common lung neoplasms.

Jeremy J Erasmus1, Homer A Macapinlac

  • 1Division of Diagnostic Imaging, Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Seminars in Nuclear Medicine
|June 12, 2012
PubMed
Summary

Positron emission tomography (PET) with 18F-2-deoxy-d-glucose (FDG) has limitations in diagnosing certain lung cancers, like subsolid nodules and carcinoid tumors. New radiotracers are being developed to improve detection and staging accuracy for these challenging cases.

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Management of Respiratory Motion Artefacts in 18F-fluorodeoxyglucose Positron Emission Tomography using an Amplitude-Based Optimal Respiratory Gating Algorithm
06:53

Management of Respiratory Motion Artefacts in 18F-fluorodeoxyglucose Positron Emission Tomography using an Amplitude-Based Optimal Respiratory Gating Algorithm

Published on: July 23, 2020

Related Experiment Videos

Last Updated: May 21, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Management of Respiratory Motion Artefacts in 18F-fluorodeoxyglucose Positron Emission Tomography using an Amplitude-Based Optimal Respiratory Gating Algorithm
06:53

Management of Respiratory Motion Artefacts in 18F-fluorodeoxyglucose Positron Emission Tomography using an Amplitude-Based Optimal Respiratory Gating Algorithm

Published on: July 23, 2020

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Radiology

Background:

  • Computed tomography (CT) and 18F-2-deoxy-d-glucose (FDG) Positron Emission Tomography (PET) are crucial for non-small cell lung cancer (NSCLC) diagnosis and staging.
  • CT excels at primary tumor evaluation, while PET aids in detecting nodal and distant metastases.
  • Both CT and PET have limitations, particularly with subsolid nodules and carcinoid tumors due to low FDG avidity.

Purpose of the Study:

  • To review the utility of PET in diagnosing and staging uncommon lung neoplasms.
  • To discuss the limitations of FDG-PET in specific lung cancer subtypes.
  • To explore novel radiotracers targeting different metabolic pathways for improved diagnostic accuracy.

Main Methods:

  • Review of current literature on PET and CT imaging in NSCLC.
  • Analysis of FDG-PET limitations in subsolid nodules and carcinoid lung tumors.
  • Discussion of emerging radiotracers and their potential applications.

Main Results:

  • FDG-PET demonstrates reduced accuracy in subsolid nodules and carcinoid tumors.
  • Misinterpretation of imaging can significantly impact NSCLC diagnosis and staging.
  • Novel radiotracers offer potential to overcome FDG-PET limitations.

Conclusions:

  • Awareness of FDG-PET limitations is essential for managing patients with subsolid nodules and carcinoid lung tumors.
  • Development of advanced radiotracers is critical for improving diagnosis, staging, and treatment monitoring in NSCLC.
  • Future research should focus on validating new tracers for these challenging lung cancer types.